15-Year Study Finds Treatment Gaps Exist for Patients with Peripheral Arterial Disease; More Consistent Use of Life-Saving Medications Recommended

A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.

Read more

Omega-3 Continues to Show Protection Against Heart Disease-Related Death, Without Prostate Cancer Risk

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.

Read more

Intermittent Fasting Increases Longevity in Cardiac Catheterization Patients

In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don’t.

Read more

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows

Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association’s Scientific Sessions 2019.

Read more

Mount Sinai Researchers Develop Novel Method to Identify Patterns Among Patients With Multiple Chronic Conditions

A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).

Read more

MIDDLE-AGED ADULTS WITH BORDERLINE PERSONALITY DISORDER POTENTIALLY AT HIGHER RISK FOR HEART ATTACKS, STUDY SAYS

Middle-aged adults who show symptoms of borderline personality disorder may be at greater risk for a heart attack, as they show physical signs of worsening cardiovascular health more than other adults, according to research published by the American Psychological Association.

Read more

Chronic kidney disease patients at increased risk of adverse cardiovascular outcomes, Mayo Clinic study finds

Chronic kidney disease, which afflicts an estimated 6.4% of U.S. adults 45 and older, is associated with an increased risk of heart attack and other adverse cardiovascular outcomes, according to new research from Mayo Clinic.

Read more

New Heart Attack Registry to Provide Unprecedented Insight into STEMI Occurrence, Treatment in North India

A new study published in Clinical Cardiology introduces the North Indian (NORIN) ST‐Segment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in January of this year. The prospective cohort study’s first author, Sameer Arora, MD, UNC School of Medicine cardiology fellow and preventive medicine resident

Read more

Developing Electrically Active Materials to Repair Damaged Hearts

When a heart attack occurs, muscle in the heart tissue can be scarred, interfering with electrical activity necessary for healthy heart function. Using artificial materials to patch or rebuild damaged parts has been tried but only recently has work focused on the electrical properties needed for proper cardiac operation. In this week’s APL Bioengineering, investigators review the use of electrically conductive biomaterials for heart repair and treatment.

Read more

Blocking a Hormone’s Action in Immune Cells May Reduce Heart Disease Risk

Blocking the mineralocorticoid receptor (MR)—a protein that helps maintain normal levels of salt and water in the body—in immune cells may help reduce the risk of heart attack and stroke by improving blood vessel health. The study will be presented today at the American Physiological Society (APS) Aldosterone and ENaC in Health and Disease: The Kidney and Beyond Conference in Estes Park, Colo.

Read more